Lovastatin decreases coenzyme Q levels in humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 87, Issue 22, 1990, Pages 8931-8934

  Folkers, Karl ^a   Langsjoen, Per ^b   Willis, Richard ^a   Richardson, Phillip ^a   Xia, L I Jun ^a   Ye, Chun Q U ^a   Tamagawa, Hiroo ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; Drug side effects; Hypercholesterolemia; Ubiquinone

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVINOLIN; UBIQUINONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CASE REPORT; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADOLESCENT; CARDIAC OUTPUT; CASE REPORT; CORONARY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGE; MYOCARDIAL CONTRACTION; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; UBIQUINONE;

ANIMALIA;

EID: 0025242794     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.87.22.8931     Document Type: Article

References (14)

1. Friedman, G. D., Kannel, W. B., Dawber, T. R. & McNamara, P. M. (1966) Am. J. Epidemiol. 83, 366-378.
2. Shaper, A. G., Pocock, S. J., Walker, M., Phillips, A. N., Whitehead, T. P. & Macfarlane, P. W. (1985) J. Epidemiol. Community Health 39, 197-209.
3. Endo, A., Kuroda, M. & Tsujita, Y. (1976) J. Antibiot. 29, 1346-1348.
4. Brown, A. G., Smale, T. C., King, T. J., Hasenkamp, R. & Thompson, R. H. (1976) J. Chem. Soc. Perkin Trans. 1, 1165-1170.
5. Alberts, A. W., Chen, J., Kurin, G., Hunt, V., Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J. & Springer, J. (1980) Proc. Natl. Acad. Sci. USA 77, 3957-3961.
6. Merck Sharp & Dohme (1988) Product Monogr. 11, L5920-10, 1288.3561.
7. Folkers, K., Wantabe, T. & Kaji, M. (1977) J. Mol. Med. 2, 431-460.
8. Langsjoen, P. H., Folkers, K., Lyson, K., Muratsu, K., Lyson, T. & Langsjoen, P. (1988) Klin. Wochenschr. 66, 583-590.
9. Langsjoen, P. H., Langsjoen, P. & Folkers, K. (1990) Am. J. Cardiol. 65, 521-523.
10. 10, eds. Folkers, K. & Yamamura, Y. (Elsevier Science, New York), Vol. 5, pp. 269-281.
11. 10, eds. Folkers, K. & Yamamura, Y. (Elsevier Science, New York), Vol. 5, pp. 281-290.
12. 10, eds. Folkers, K. & Yamamura, Y. (Elsevier Science, New York), Vol. 5, pp. 291-302.
13. Willis, R. A., Folkers, K., Tucker, J. L., Ye, C.-Q., Xia, L.-J. & Tamagawa, H. (1990) Proc. Natl. Acad. Sci. USA 87, 8928-8930.
14. Merck and Co., Inc. (1990) First Quarter Report.